Literature DB >> 8375512

Antibodies against the major brain isoforms of 14-3-3 protein. An antibody specific for the N-acetylated amino-terminus of a protein.

H Martin1, Y Patel, D Jones, S Howell, K Robinson, A Aitken.   

Abstract

14-3-3 proteins are apparently ubiquitous eukaryotic proteins that comprise a large number of isoforms. They have been implicated in the regulation of a wide range of biological processes [reviewed in Aitken et al. (1992) Trends Biochem. Sci. 17, 498-501]. We have raised specific antibodies against each mammalian brain isoform of 14-3-3 employing peptides synthesised from the amino-terminal regions. The peptides were, like the proteins from mammalian brain, N-acetylated. The antiserum specific for the epsilon isoform did not recognise the recombinant form of this protein (lacking the N-acetyl co-translational modification) expressed in E. coli until it was chemically acetylated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8375512     DOI: 10.1016/0014-5793(93)80356-y

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  24 in total

Review 1.  Functional specificity in 14-3-3 isoform interactions through dimer formation and phosphorylation. Chromosome location of mammalian isoforms and variants.

Authors:  Alastair Aitken
Journal:  Plant Mol Biol       Date:  2002-12       Impact factor: 4.076

Review 2.  Proteomic analysis of the presynaptic active zone.

Authors:  W Volknandt; M Karas
Journal:  Exp Brain Res       Date:  2012-02-22       Impact factor: 1.972

3.  Structure of the 14-3-3ζ-LKB1 fusion protein provides insight into a novel ligand-binding mode of 14-3-3.

Authors:  Sheng Ding; Ruiqing Zhou; Yaqin Zhu
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-08-25       Impact factor: 1.056

4.  14-3-3 inhibits the Dictyostelium myosin II heavy-chain-specific protein kinase C activity by a direct interaction: identification of the 14-3-3 binding domain.

Authors:  M Matto-Yelin; A Aitken; S Ravid
Journal:  Mol Biol Cell       Date:  1997-10       Impact factor: 4.138

5.  Molecular evolution of the 14-3-3 protein family.

Authors:  W Wang; D C Shakes
Journal:  J Mol Evol       Date:  1996-10       Impact factor: 2.395

Review 6.  14-3-3 proteins in neuronal development and function.

Authors:  E M Skoulakis; R L Davis
Journal:  Mol Neurobiol       Date:  1998-06       Impact factor: 5.590

7.  Immunocytochemical detection of 14-3-3 in primary nervous system tumors.

Authors:  Wei-Dong Cao; Xiang Zhang; Jian-Ning Zhang; Zhi-Jun Yang; Hai-Ning Zhen; Guang Cheng; Bian Li; Dakuan Gao
Journal:  J Neurooncol       Date:  2005-11-15       Impact factor: 4.130

8.  Characterization of 14-3-3 proteins in adrenal chromaffin cells and demonstration of isoform-specific phospholipid binding.

Authors:  D Roth; A Morgan; H Martin; D Jones; G J Martens; A Aitken; R D Burgoyne
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

9.  Mechanism of inhibition of protein kinase C by 14-3-3 isoforms. 14-3-3 isoforms do not have phospholipase A2 activity.

Authors:  K Robinson; D Jones; Y Patel; H Martin; J Madrazo; S Martin; S Howell; M Elmore; M J Finnen; A Aitken
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

10.  Increases in expression of 14-3-3 eta and 14-3-3 zeta transcripts during neuroprotection induced by delta9-tetrahydrocannabinol in AF5 cells.

Authors:  Jia Chen; Chun-Ting Lee; Stacie L Errico; Kevin G Becker; William J Freed
Journal:  J Neurosci Res       Date:  2007-06       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.